LONDON, July 27 (Reuters) - GlaxoSmithKline plans275 million pounds ($361 million) of new investments at threedrug manufacturing sites in Britain, signalling its confidencein the country despite last month's vote to leave the EuropeanUnion. (Reporting by Ben Hirschler; Editing by David Holmes)
LONDON BROKER RATINGS: RBC cuts HSBC; Liberum cuts Glencore
(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:
Read more